HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Garcia-Porrua Selected Research

Genetic Markers (Genetic Marker)

8/2003Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos Garcia-Porrua Research Topics

Disease

9Rheumatoid Arthritis
01/2019 - 06/2002
9Giant Cell Arteritis (Horton Disease)
01/2006 - 08/2003
8Purpura
01/2006 - 05/2002
5Atherosclerosis
01/2012 - 06/2004
4Inflammation (Inflammations)
02/2007 - 09/2005
3Nephritis
01/2006 - 05/2002
3Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
12/2003 - 03/2002
3Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
10/2002 - 05/2002
2Vasculitis (Vasculitides)
06/2006 - 05/2002
2Disease Susceptibility (Diathesis)
12/2004 - 08/2003
2Vascular Skin Diseases
02/2004 - 11/2002
2Erythema Nodosum
02/2004 - 08/2002
1Meningitis
02/2012
1Rheumatoid Vasculitis
02/2006
1Hypoalbuminemia
09/2005
1Anemia
09/2005
1Pathologic Constriction (Stenosis)
09/2005
1Thrombocytosis (Thrombocythemia)
09/2005
1Stroke (Strokes)
09/2005
1Fever (Fevers)
08/2004
1Leukocytosis (Pleocytosis)
10/2002
1Tubulointerstitial nephritis and uveitis
10/2002
1Uveitis
10/2002
1Sarcoidosis (Schaumann Disease)
08/2002
1Nephrotic Syndrome (Syndrome, Nephrotic)
07/2002
1Renal Insufficiency (Renal Failure)
07/2002

Drug/Important Bio-Agent (IBA)

6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 06/2004
6HLA-DRB1 Chains (HLA DRB1)IBA
02/2007 - 05/2002
2Biomarkers (Surrogate Marker)IBA
02/2007 - 09/2005
2C-Reactive ProteinIBA
02/2007 - 07/2005
2SteroidsIBA
06/2006 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 09/2005
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2005 - 06/2005
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2005 - 06/2005
2Macrophage Migration-Inhibitory FactorsIBA
01/2005 - 08/2002
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
02/2004 - 09/2003
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2004 - 03/2002
2EpitopesIBA
06/2003 - 06/2002
1CalciumIBA
02/2012
1Adalimumab (Humira)FDA Link
01/2012
1Antirheumatic Agents (DMARD)IBA
01/2012
1CytokinesIBA
12/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2006
1Alkaline PhosphataseIBA
09/2005
1Hemoglobins (Hemoglobin)IBA
09/2005
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
08/2005
1Indicators and Reagents (Reagents)IBA
07/2005
1InterferonsIBA
12/2004
1Interleukin-4 (Interleukin 4)IBA
12/2004
1Interferon-gamma (Interferon, gamma)IBA
12/2004
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2004
1Interleukin-1beta (Interleukin 1 beta)IBA
02/2004
1InterleukinsIBA
02/2004
1Genetic Markers (Genetic Marker)IBA
08/2003
1HLA-DRB1*04 antigenIBA
06/2003
1Corticotropin-Releasing HormoneIBA
05/2003
1Chemokine CCL5IBA
11/2002
1Peptides (Polypeptides)IBA
11/2002
1Interleukin-8 (Interleukin 8)IBA
11/2002
1Orlistat (Xenical)FDA Link
10/2002
1Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2002
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2002
1HLA Antigens (Human Leukocyte Antigens)IBA
06/2002
1HLA-B35 Antigen (HLA B35 Antigen)IBA
05/2002
1HLA-B Antigens (HLA-B)IBA
05/2002

Therapy/Procedure

6Therapeutics
01/2012 - 10/2002